知镜 Cognispect · 医学文献与研究工作台

Severe obesity, chronic kidney disease, and respiratory complications in hospitalized patients with HFpEF: A nationwide analysis.

Sattarzadeh A, Lahoud C, Jia K, Dulnuan K.
American heart journal plus : cardiology research and practice · 2026-10-30 · PMID 43036789

文献摘要

Heart failure with preserved ejection fraction (HFpEF) commonly coexists with obesity and chronic kidney disease (CKD), creating a high-risk cardiovascular-kidney-metabolic phenotype. Although an obesity paradox has been described in HFpEF, whether this paradigm holds for respiratory outcomes across CKD stages remains unclear. We conducted a retrospective cohort study using the National Inpatient Sample (NIS) from 2016 to 2020. Adult HFpEF hospitalizations were stratified by BMI category and CKD stage. To reduce confounding by frailty and advanced systemic illness, hospitalizations with underweight BMI, protein-calorie malnutrition, cachexia, end-stage renal disease/dialysis, metastatic malignancy, active chemotherapy, cirrhosis/advanced liver disease, and amyloidosis were excluded. Primary outcomes were acute respiratory failure and endotracheal intubation/mechanical ventilation. Multivariable logistic regression was performed within each CKD stage, with hospitalizations without a coded BMI ≥25 kg/m 2 as the reference group. Among 1,182,104 HFpEF hospitalizations, class III obesity (BMI ≥40 kg/m 2 ) was the only obesity category consistently associated with both primary outcomes across CKD stages. Acute respiratory failure was increased with class III obesity from CKD stage 1 through stage 4 (adjusted odds ratio [aOR] 1.549, 95% confidence interval [CI] 1.173-2.047 to aOR 1.500, 95% CI 1.440-1.562). Increased odds of intubation/mechanical ventilation emerged in CKD stage 2 and persisted through stage 4. In CKD stage 4, class III obesity was additionally associated with vasopressor use, acute kidney injury, and in-hospital mortality. In hospitalized HFpEF patients, severe obesity was associated with a respiratory-vulnerable phenotype across CKD stages 1-4, without a clear stepwise increase with CKD stage, challenging a uniformly protective obesity paradox. These hypothesis-generating findings require confirmation with clinical data.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。